M
Mazowieckie Centrum Badan Klinicznych | Grodzisk Mazowiecki, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
R935788
RTX-GRT7039
Ocrelizumab
Povorcitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple s...
Active, not recruiting
Multiple Sclerosis, Primary Progressive
Drug: Ocrelizumab
Drug: Placebo
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Enrolling
Prurigo Nodularis
Drug: Povorcitinib
Drug: Placebo
Trial sponsors
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems